Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

VitaNova Life Sciences (YJGJ) Gross Margin (2017 - 2026)

VitaNova Life Sciences (YJGJ) has disclosed Gross Margin for 3 consecutive years, with 61.06% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin rose 772.0% year-over-year to 61.06%, compared with a TTM value of 60.03% through Oct 2025, down 244.0%, and an annual FY2025 reading of 59.19%, down 699.0% over the prior year.
  • Gross Margin was 61.06% for Q4 2025 at VitaNova Life Sciences, down from 66.2% in the prior quarter.
  • Across five years, Gross Margin topped out at 100.0% in Q1 2024 and bottomed at 53.35% in Q4 2024.